Ann: AGM- other than Chairman's address, page-6

This article some months ago gives a clue as to what has been happening getting to "production equivalent systems". The operative word is "prove" so I think we are at the point of "when" not "if" in terms of getting to market. The goal in terms of "develop and refine" the instrument would be largely complete in the new system considering this research was done using a Five1. Which also shows what a great instrument that is and what it`s successor "ViewNvivo" should be.

The eventual goal of this research is to develop the instrument to a degree that it is FDA approved and can speed up the process of pathology interpretation of brain tumor tissue. Hopefully this technology will improve brain tumor surgery by allowing for a more tailored removal of the tissue and allowing for more aggressive management at the tumor border.
Next steps for this research will see new refinements in the endomicroscope instrument and development of new tumor cell stains and probes that light up the tumor cells to an even greater degree.

http://medicalxpress.com/news/2016-05-barrow-imaging-tool-surgeon.html